Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (15) , 4354-4358
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA PolymeraseJournal of Medicinal Chemistry, 2006
- A Highly Efficient, Asymmetric Synthesis of Benzothiadiazine-Substituted Tetramic Acids: Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA PolymeraseOrganic Letters, 2005
- The hepatitis C virus replicon system: From basic research to clinical applicationJournal of Hepatology, 2005
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis CReviews in Medical Virology, 2003
- Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA PolymeraseJournal of Biological Chemistry, 2002
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- [4] RNA-dependent RNA polymerase of hepatitis C virus1996
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990